STERIS (NYSE:STE) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of STERIS plc (NYSE:STE). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on May 1st. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Revvity (NYSE:RVTY) on 5/1/2026.
• Sold $1,001 – $15,000 in shares of Flex (NASDAQ:FLEX) on 5/1/2026.
• Purchased $1,001 – $15,000 in shares of LPL Financial (NASDAQ:LPLA) on 5/1/2026.
• Purchased $1,001 – $15,000 in shares of FirstService (NASDAQ:FSV) on 5/1/2026.
• Sold $1,001 – $15,000 in shares of SS&C Technologies (NASDAQ:SSNC) on 5/1/2026.
• Purchased $1,001 – $15,000 in shares of Wayfair (NYSE:W) on 5/1/2026.
• Purchased $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 5/1/2026.
• Purchased $1,001 – $15,000 in shares of Sensata Technologies (NYSE:ST) on 5/1/2026.
• Purchased $1,001 – $15,000 in shares of Veralto (NYSE:VLTO) on 5/1/2026.
• Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 4/29/2026.

STERIS Stock Down 2.7%

STERIS stock opened at $201.95 on Tuesday. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. The firm’s 50-day simple moving average is $222.37 and its 200 day simple moving average is $243.74. The stock has a market cap of $19.81 billion, a PE ratio of 28.17 and a beta of 0.95.

STERIS (NYSE:STE) last posted its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing the consensus estimate of $2.86 by ($0.03). STERIS had a net margin of 12.15% and a return on equity of 14.34%. The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the business posted $2.74 EPS. The company’s quarterly revenue was up 6.7% on a year-over-year basis. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Research analysts predict that STERIS plc will post 10.22 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 8th will be issued a dividend of $0.63 per share. The ex-dividend date is Monday, June 8th. This represents a $2.52 annualized dividend and a yield of 1.2%. STERIS’s payout ratio is 35.15%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Wall Street Zen lowered STERIS from a “strong-buy” rating to a “buy” rating in a report on Sunday, April 26th. Weiss Ratings cut STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday, April 16th. Five research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $275.20.

Insider Buying and Selling

In other STERIS news, Director Cynthia L. Feldmann sold 3,098 shares of the stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $237.21, for a total transaction of $734,876.58. Following the completion of the transaction, the director owned 705 shares in the company, valued at $167,233.05. This trade represents a 81.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.07% of the stock is currently owned by company insiders.

Key Headlines Impacting STERIS

Here are the key news stories impacting STERIS this week:

• Positive Sentiment: STERIS raised fiscal 2027 EPS guidance to $11.10-$11.30, topping analyst expectations and signaling confidence in continued demand. Reuters article
• Positive Sentiment: Revenue rose 6.7% year over year in the quarter, and operating profit and net income improved meaningfully, showing the core business is still expanding. GlobeNewswire article
• Neutral Sentiment: The company’s results were broadly close to expectations, with only a small EPS and revenue miss, so investors may see the quarter as mixed rather than weak. Zacks article
• Negative Sentiment: The stock is under pressure because the quarter technically missed consensus EPS and revenue estimates, which can prompt profit-taking after the recent run. Quiver Quantitative article

Institutional Investors Weigh In On STERIS

Large investors have recently modified their holdings of the stock. Steigerwald Gordon & Koch Inc. purchased a new position in STERIS in the third quarter valued at approximately $25,000. Board of the Pension Protection Fund bought a new stake in shares of STERIS in the fourth quarter valued at $25,000. Activest Wealth Management lifted its position in shares of STERIS by 423.8% during the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 89 shares during the last quarter. Measured Wealth Private Client Group LLC bought a new position in shares of STERIS during the 4th quarter worth $28,000. Finally, Harbor Investment Advisory LLC increased its holdings in STERIS by 115.4% in the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 60 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.